Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples

microRNAs: Master Regulators as Potential Therapeutics in Cancer

(2011) Michela Garofalo et al.   Annual Review of Pharmacology and Toxicology

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer

(2011) Lucy Heinemann et al.   BMC CANCER

Inhibition of miR-193a Expression by Max and RXR  Activates K-Ras and PLAU to Mediate Distinct Aspects of Cellular Transformation

(2011) D. Iliopoulos et al.   CANCER RESEARCH

CUG2, a novel oncogene confers reoviral replication through Ras and p38 signaling pathway

(2010) E-H Park et al.   CANCER GENE THERAPY

Double-Negative Feedback Loop between Reprogramming Factor LIN28 and microRNA let-7 Regulates Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells

(2010) X. Yang et al.   CANCER RESEARCH

Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers

(2010) K. J. Harrington et al.   CLINICAL CANCER RESEARCH

Efficacy of oncolytic reovirus against human gastric cancer with peritoneal metastasis in experimental animal model

(2010) Kawaguchi   INTERNATIONAL JOURNAL OF ONCOLOGY

Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice

(2010) Timothy Kottke et al.   JOURNAL OF CLINICAL INVESTIGATION

In situ detection of microRNAs in paraffin embedded, formalin fixed tissues and the co-localization of their putative targets

(2010) Gerard J. Nuovo   METHODS

The Effect of Cell Cycle Synchronization on Tumor Sensitivity to Reovirus Oncolysis

(2010) Lucy Heinemann et al.   MOLECULAR THERAPY

Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma

(2009) H. S. Pandha et al.   CLINICAL CANCER RESEARCH

Improved Systemic Delivery of Oncolytic Reovirus to Established Tumors Using Preconditioning with Cyclophosphamide-Mediated Treg Modulation and Interleukin-2

(2009) T. Kottke et al.   CLINICAL CANCER RESEARCH

let-7 MicroRNA Transfer in Pancreatic Cancer-Derived Cells Inhibits In Vitro Cell Proliferation but Fails to Alter Tumor Progression

(2009) Jérôme Torrisani et al.   HUMAN GENE THERAPY

Intravenous administration of Reolysin®, a live replication competent RNA virus is safe in patients with advanced solid tumors

(2009) Radharani Gollamudi et al.   INVESTIGATIONAL NEW DRUGS

Reciprocal Human Dendritic Cell-Natural Killer Cell Interactions Induce Antitumor Activity Following Tumor Cell Infection by Oncolytic Reovirus

(2009) R. J. Prestwich et al.   JOURNAL OF IMMUNOLOGY

Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells

(2009) Shizuko Sei et al.   Molecular Cancer

Reovirus: Viral Therapy for Cancer ‘as Nature Intended’

(2008) C. Comins et al.   CLINICAL ONCOLOGY

Reovirus therapy in cancer: has the orphan virus found a home?

(2008) Timothy A Yap et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS